Danaher Corp. Stock Slides 4.4%, Underperforms Peers
Dow Jones2026/10/01 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Danaher Corp. slipped 4.4% to $211.76 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,666.45 and the Dow Jones Industrial Average remaining mostly unchanged at 50,926.56.
This was the stock's third consecutive day of losses.
Danaher Corp. closed 12.8% short of its 52-week high of $242.80, which the company reached on January 22nd.
The stock underperformed when compared to some of its peers, as Thermo Fisher Scientific Inc. fell 3.3% to $652.51, Abbott Laboratories fell 2.2% to $96.69, and Medtronic PLC rose 0.17% to $86.44.
Trading volume totaled 5.3 million, compared to the 50-day average of 4.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 01, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
Crypto prices
More
